Clostridium difficile
At sikre korrekt og optimal behandling af toksinproducerende Clostridium difficile infektion.
Vejledningen omfatter sundhedspersonale på hospitaler i Region Hovedstaden, der diagnosticerer og behandler patienter med toksinproducerende C. difficile infektion.
Hospitalsdirektioner er ansvarlige for at distribuere vejledningen til alle relevante kliniske afdelinger.
Center-, afdelings- og klinikledelser er ansvarlige for at vejledningen implementeres i relevante afdelinger.
Al-Nassir WN, Sethi AK, Li Y, Pultz MJ, Riggs MM, Donskey CJ. Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease. Antimicrob Agents Chemother 2008; 52: 2403-2406.
Al-Nassir WN, Sethi AK, Nerandzic MM, Bobulsky GS, Jump RLP, Donskey K. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin. CID 2008; 47: 56-62.
Belmares J, Gerding D, Parada J, Miskevics S, Weaver F, Johnson S. Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system. J Infect 2007; 55: 495-501.
Bricker E, Garg R, Nelson R, Loza A, Novak T, Hansen J. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database of Systematic Reviews 2005, Issue 1. Art.no.:CD004610. DOI 10.1002/14651858. CD004610.pub.2.
Carstensen JW, Chehri M, Schønning K, Rasmussen SC, Anhøj J, Godtfredsen NS,Andersen CØ, Petersen AM. Use of prophylactic Saccharomyces boulardii to prevent Clostridium difficile infection in hospitalized patients: a controlled prospective intervention study. Eur J Clin Microbiol Infect Dis. 2018. Aug;37(8):1431-1439
Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo V, McDonald IC, Pepin J, Wilcox MH. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Inf Contr Hosp Epidemiol 2010, 31: 431-455.
Debast SB, Bauer MP, Kuijper EJ; European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014 Mar;20 Suppl 2:1-26.
Drekonja DM, Butler M, MacDonald R, Bliss D, Filice GA, Rector TS, et al. Comparative effectiveness of Clostridium difficile treatments: A systematic review. Ann Intern Med 2011; 155: 839–847
Edlund C, Barkholt L, Olsson-Liljekvist B, Nord CE. Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy. Clin Infect Dis 1997; 25: 729-732.
Fekety R, Silva J, Kauffmann C, Buggy B, Deery HG. Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: Comparison of two dosage regimens. Am J Med 1989; 86: 15-19.
Gerding D, Johnson S. Management of Clostridium difficile infection: Thinking inside and outside the box. CID 2010; 51: 1306 – 1313.
Kuijper E, Wilcox M. Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection ? CID 2008; 47: 63-65.
McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Loo V, Shaklee Sammons J, Sandora TJ, Wilcox MH Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).. Clin Infect Dis. 2018 Mar 19;66(7):987-994
Nelson RL. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database of Systematic Reviews, Issue 3. Art. No.: CD004610. DOI:10.1002/14651858. CD004610.pub3.
Oake N, Taljaard M, van Walraven J, Wilson K, Roth V, Forster AJ. The effect of hospital-acquired Clostridium difficile infection on in-hospital mortality. Arch Intern Med 2010; 170: 1804-1810.
O’Horo JC, Jindai K, Kunzer B, Safdar N. Treatment of recurrent Clostridium difficile: a systematic review. Infection DOI 10.1007/s15010-013-0496-x July 2013
Postigo R, Kim JH. Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis. Infection 2012; 40: 643-648.
Sethi AK, Al-Nassir WN, Nerandzic MM, Donskey CJ. Skin and environmental contamination with vancomycin resistant enterococci in patients receiving oral metronidazole or oral vancomycin treatment for Clostridium difficile-associated disease. Infect Contr Hosp Epidemiol 2009; 30: 13-17.
Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing clostridium difficile diarrhoea in six patients. Lancet 1989; May 27. 1156-1160.
Wilson V, Cheek L, Satta G, Walker-Bone K, Cubbon M, Citron D, Gerding D, Llewelyn MJ. Predictors of death after Clostridium difficile infection: A report on 128 strain-typed cases from a teaching hospitalin the United Kingdom. CID 2010; 50: e77-e81.
Zar FA, Bakkanagari SR, Moorthi KMLST, Davis M. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. CID 2007; 45: 302-307.
Regionale vejledninger
Isolation - hvilke patienter skal isoleres og hvordan?
Isolation - kontaktsmitte og dråbesmitte